Envista Holdings Corporation (NVST)

Market Cap	3.50B
Revenue (ttm)	2.57B
Net Income (ttm)	-100.20M
Shares Out	171.86M
EPS (ttm)	-0.60
PE Ratio	n/a
Forward PE	14.06
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,769,777
Open	19.48
Previous Close	20.02
Day's Range	19.42 - 20.61
52-Week Range	18.96 - 38.68
Beta	1.35
Analysts	Buy
Price Target	27.56 (+35.16%)
Earnings Date	May 1, 2024

About NVST

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Sep 18, 2019
• Employees: 12,800
• Stock Exchange: NYSE
• Ticker Symbol: NVST

Analyst Forecast

According to 11 analysts, the average rating for NVST stock is "Buy." The 12-month stock price forecast is $27.56, which is an increase of 35.16% from the latest price.

Price Target

$27.56

(35.16% upside)

Analyst Consensus: Buy